Mike Motz is the CEO of Walgreens, America’s second-largest pharmacy chain. Motz was appointed CEO on August 28, 2025, the same day private equity firm Sycamore Partners completed its approximately $10 billion acquisition of Walgreens Boots Alliance, taking the nearly 100-year-old company private. A Canadian-born retail veteran who began working at age 14 at Miracle […]

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen, is one of the world’s largest pharmaceutical distribution companies with annual revenue exceeding $321 billion and operations spanning more than 50 countries. Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who transitioned to the role of Executive Chairman. […]

Sanofi S.A., one of the world’s largest pharmaceutical companies, was founded in 1973 and is headquartered in Paris, France. In February 2026, Sanofi named Belén Garijo as its next Chief Executive Officer, replacing Paul Hudson after a turbulent period of R&D setbacks. Garijo, a physician by training and former CEO of Merck KGaA, will formally […]

Cardinal Health, Inc. (NYSE: CAH) is a Fortune 14 global healthcare services and products company headquartered in Dublin, Ohio. Cardinal Health CEO Jason Hollar leads the $222.6 billion enterprise and a workforce of approximately 48,000 employees across pharmaceutical distribution, specialty solutions, and medical products. Appointed CEO in September 2022 after serving as the company’s CFO, […]

Merck & Co., Inc. (NYSE: MRK), one of the world’s largest pharmaceutical companies, was founded in 1891 and is headquartered in Rahway, New Jersey. Today, Merck CEO Robert M. Davis leads the company’s $65 billion business and a global workforce of approximately 69,000 employees. Appointed CEO on July 1, 2021, succeeding the legendary Kenneth Frazier, […]

GSK plc (formerly GlaxoSmithKline), one of the world’s largest pharmaceutical and biotechnology companies, was founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. Today, GSK CEO Luke Miels leads the company’s $40+ billion business and a global workforce of approximately 70,000 employees across medicines, vaccines, and consumer healthcare. Appointed CEO on January […]

Stephen J. Hemsley is the Chairman and CEO of UnitedHealth Group (NYSE: UNH), the largest health insurance company in the United States with $447.6 billion in revenue for 2025. Born on June 4, 1952, Hemsley returned to the CEO role on May 13, 2025, after Andrew Witty stepped down for personal reasons. He previously served […]

David Joyner is the President, CEO, and Chairman of CVS Health Corporation (NYSE: CVS), one of the largest healthcare companies in the world with over $402 billion in annual revenue and more than 300,000 employees. Appointed President and CEO on October 17, 2024, and elected Chairman of the Board effective January 1, 2026, Joyner brought […]

AbbVie Inc., one of the world’s largest biopharmaceutical companies, was spun off from Abbott Laboratories in 2013 and is headquartered in North Chicago, Illinois. Today, AbbVie CEO Robert A. Michael leads the company’s $61 billion business and a global team of approximately 50,000 employees across more than 175 countries. Appointed CEO in July 2024 and […]

Kristin Peck – CEO of Zoetis Inc. Kristin Peck is the CEO of Zoetis Inc. (NYSE: ZTS), the world’s largest animal health company with $9.5 billion in annual revenue. Appointed CEO in January 2020, Peck was instrumental in Zoetis’s 2013 IPO spin-off from Pfizer and has since grown the company into a global leader in […]

Eric M. Green – President, CEO & Chair, West Pharmaceutical Services Eric M. Green is the President, Chief Executive Officer, and Chair of the Board of West Pharmaceutical Services, Inc. (NYSE: WST). Green has led West Pharmaceutical since April 2015 and became Chair in May 2022. Under his decade-long leadership, the specialty pharmaceutical supplier surpassed […]

⚠ Leadership Update: Kevin Ali served as CEO of Organon & Co. from June 2021 to October 2025. Ali resigned on October 26, 2025 following an internal audit committee investigation into improper Nexplanon sales practices involving U.S. wholesalers. Joseph Morrissey (EVP, Manufacturing & Supply) is serving as Interim CEO while the Board conducts a search […]

⚠ Leadership Update: Paul Hudson served as CEO of Sanofi from September 2019 until February 2026. He was removed by the Board on February 12, 2026. Olivier Charmeil is serving as interim CEO, and Belén Garijo (former CEO of Merck KGaA) will formally assume the CEO role at Sanofi’s Annual General Meeting on April 29, […]

Roche, the world’s largest biotech company and a global leader in diagnostics, was founded in 1896 by Fritz Hoffmann-La Roche in Basel, Switzerland. Today, Roche CEO Thomas Schinecker leads the company’s CHF 61.5 billion business and a global workforce of over 103,000 employees across more than 100 countries. Appointed Group CEO in March 2023, Schinecker […]

⚠ Leadership Update: Dame Emma Walmsley served as CEO of GSK from April 2017 to December 2025. The current CEO is Luke Miels (since January 2026). Walmsley remains with the company in an advisory capacity through September 2026 to support the transition. GSK plc (formerly GlaxoSmithKline), one of the world’s largest pharmaceutical and biotechnology companies, […]

Vas Narasimhan – CEO of Novartis AG Vas Narasimhan is the CEO of Novartis AG, the Swiss multinational pharmaceutical corporation headquartered in Basel, Switzerland. Appointed CEO in February 2018 at the age of 41, Narasimhan became one of the youngest-ever leaders of a top-10 global pharma company. Born in Pittsburgh to Indian-American parents from Tamil […]

AstraZeneca plc, one of the world’s largest pharmaceutical and biotechnology companies, was founded in 1999 through the merger of Sweden’s Astra AB and the UK’s Zeneca Group. Today, AstraZeneca CEO Sir Pascal Soriot leads the company’s $58.7 billion business and a global workforce of over 89,000 employees across more than 100 countries. Appointed in October […]